title: Duality of hepatitis B e antigen in serum of persons infected with hepatitis B virus: evidence for the nonidentity of e antigen with immunoglobulins.
abstract: Hepatitis B e antigen (HBeAg) is detected in the serum of some persons infected with hepatitis B virus. Owing to a close correlation of HBeAg and hepatitis B virus in the serum, it has been used as a practical indicator of infectivity. Two entities of HBeAg activity physicochemically different from each other were demonstrated in the serum of persons infected with hepatitis B virus. One was associated with a molecule that precipitated in 1.33 M ammonium sulfate solution, was larger than IgG, and had an electrophoretic mobility in the beta- to gamma-globulin regions and an isoelectric point of approximately pH 5.7. In contrast, the other HBeAg activity was associated with a molecule that was soluble in 1.33 M ammonium sulfate solution, was smaller than IgG, and had an electrophoretic mobility in the alpha-globulin region and an isoelectric point at pH 4.8. In spite of their marked physicochemical differences, a line of antigenic identity was clearly observed for them when they were tested against antibody to HBeAg by a them when they were tested against antibody to HBeAg by a double immunodiffusion method. The HBeAg activity associated with the large molecule was completely removed by an affinity column of anti-IgG, whereas the activity of the small molecule was not. These results indicate that, in the serum, HBeAg exists as a molecule smaller than IgG and also in association with IgG.
mesh_terms: D004589:Electrophoresis, Disc; D005590:Fractional Precipitation; D006509:Hepatitis B / Q000276:immunology*; D006511:Hepatitis B Antigens / Q000032:analysis* / Q000302:isolation & purification; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007136:Immunoglobulins; D007525:Isoelectric Focusing; D008970:Molecular Weight
chemical_list: D006511:Hepatitis B Antigens; D007074:Immunoglobulin G; D007136:Immunoglobulins
references.citation: Ann Inst Pasteur (Paris). 1960 Jul;99:13-27
references.pmid: 13828667
references.citation: Ann N Y Acad Sci. 1964 Dec 28;121:404-27
references.pmid: 14240539
references.citation: Lancet. 1971 Dec 4;2(7736):1225-7
references.pmid: 4143591
references.citation: N Engl J Med. 1978 Feb 23;298(8):439-41
references.pmid: 622119
references.citation: Am J Epidemiol. 1977 Feb;105(2):94-8
references.pmid: 835566
references.citation: Proc Natl Acad Sci U S A. 1977 Apr;74(4):1702-6
references.pmid: 266209
references.citation: Proc Natl Acad Sci U S A. 1977 May;74(5):2149-51
references.pmid: 266736
references.citation: J Immunol. 1977 Nov;119(5):1556-9
references.pmid: 915268
references.citation: Infect Immun. 1976 Sep;14(3):631-5
references.pmid: 965088
references.citation: N Engl J Med. 1976 Oct 21;295(17):909-13
references.pmid: 967200
references.citation: Lancet. 1973 Oct 20;2(7834):869-73
references.pmid: 4126916
references.citation: J Immunol. 1972 Nov;109(5):1017-21
references.pmid: 4116763
references.citation: Lancet. 1970 Apr 4;1(7649):695-8
references.pmid: 4190997
references.citation: J Infect Dis. 1976 Mar;133(3):339-42
references.pmid: 56411
references.citation: Clin Exp Immunol. 1975 May;20(2):209-16
references.pmid: 55324
references.citation: J Immunol. 1976 Jul;117(1):102-5
references.pmid: 819577
references.citation: J Infect Dis. 1976 Jul;134(1):85-9
references.pmid: 939924
references.citation: N Engl J Med. 1976 Apr 1;294(14):746-9
references.pmid: 943694
references.citation: Nature. 1967 Sep 30;215(5109):1491-2
references.pmid: 6059570